Barinthus Biotherapeutics (BRNS) Times Interest Earned (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Times Interest Earned of -$467.31 for Q1 2026, up 70.51% on a YoY basis from -$274.07 in Q1 2025, and up 47.47% quarter-over-quarter from -$889.62 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Times Interest Earned (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Times Interest Earned for 7 years, with the latest figure at -$467.31 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 70.51% year-over-year to -$467.31; the trailing twelve-month figure through Mar 2026 stood at -$1098.6 (up 17.21% YoY), and the FY2025 full-year result was -$1383.4, down 7.87% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$467.31, up from -$889.62 in the prior quarter.
- The five-year high for Times Interest Earned was $8.84 in Q1 2022, with the low at -$2855.4 in Q4 2023.
- Historically, Times Interest Earned has averaged -$1423.6 across 5 years, with a median of -$1523.8 in 2024.
- Annual changes were most pronounced in 2022 — Times Interest Earned jumped 479.46% — and 2025, when it plunged 110.04%.
- Barinthus Biotherapeutics' Times Interest Earned stood at $8.84 in 2022, then sank by 32409.13% to -$2855.4 in 2023, then surged by 31.74% to -$1949.2 in 2024, then jumped by 54.36% to -$889.62 in 2025, then soared by 47.47% to -$467.31 in 2026.
- The last three Times Interest Earned figures came in at -$467.31 (Q1 2026), -$889.62 (Q4 2025), and -$1158.9 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Barinthus Biotherapeutics | 27.57 Mn | -39.54 Mn | - | -467.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -467.31 |
| Dec 31, 2025 | -889.62 |
| Sep 30, 2025 | -1,158.92 |
| Jun 30, 2025 | -1,943.67 |
| Mar 31, 2025 | -1,584.62 |
| Dec 31, 2024 | -1,949.17 |
| Sep 30, 2024 | -551.76 |
| Jun 30, 2024 | -1,523.83 |
| Mar 31, 2024 | -1,409.50 |
| Dec 31, 2023 | -2,855.43 |
| Sep 30, 2023 | -2,300.71 |
| Jun 30, 2023 | -1,881.21 |
| Mar 31, 2022 | 8.84 |
| Dec 31, 2021 | -926.00 |
| Mar 31, 2021 | -2.33 |
| Dec 31, 2020 | -3.66 |
| Sep 30, 2020 | -1.47 |